These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 12360542)
21. Treatment of Parkinson's disease: levodopa as the first choice. Katzenschlager R; Lees AJ J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059 [TBL] [Abstract][Full Text] [Related]
22. Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment. Brunner H; Wetter TC; Hogl B; Yassouridis A; Trenkwalder C; Friess E Mov Disord; 2002 Sep; 17(5):928-33. PubMed ID: 12360541 [TBL] [Abstract][Full Text] [Related]
23. The relation between abnormal behaviors and REM sleep microstructure in patients with REM sleep behavior disorder. Frauscher B; Gschliesser V; Brandauer E; Ulmer H; Poewe W; Högl B Sleep Med; 2009 Feb; 10(2):174-81. PubMed ID: 18359665 [TBL] [Abstract][Full Text] [Related]
24. Loss of REM sleep features across nighttime in REM sleep behavior disorder. Arnaldi D; Latimier A; Leu-Semenescu S; Vidailhet M; Arnulf I Sleep Med; 2016 Jan; 17():134-7. PubMed ID: 26847988 [TBL] [Abstract][Full Text] [Related]
25. [The relationship between rapid eye movement electromyogram activity and sleep stability in rapid eye movement sleep behavior disorder]. Ren JF; Zhao XC; Zhong Z; Sun SH; Chen GY; Fan MM; Su CJ Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(27):2535-2540. PubMed ID: 38978378 [No Abstract] [Full Text] [Related]
32. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography. Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888 [TBL] [Abstract][Full Text] [Related]
33. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease. Nomura T; Inoue Y; Mitani H; Kawahara R; Miyake M; Nakashima K Mov Disord; 2003 Jul; 18(7):812-7. PubMed ID: 12815661 [TBL] [Abstract][Full Text] [Related]
34. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Paus S; Brecht HM; Köster J; Seeger G; Klockgether T; Wüllner U Mov Disord; 2003 Jun; 18(6):659-67. PubMed ID: 12784269 [TBL] [Abstract][Full Text] [Related]
35. Relation between subtype of Parkinson's disease and REM sleep behavior disorder. Kumru H; Santamaria J; Tolosa E; Iranzo A Sleep Med; 2007 Nov; 8(7-8):779-83. PubMed ID: 17904419 [TBL] [Abstract][Full Text] [Related]
36. Usefulness of the SINBAR electromyographic montage to detect the motor and vocal manifestations occurring in REM sleep behavior disorder. Iranzo A; Frauscher B; Santos H; Gschliesser V; Ratti L; Falkenstetter T; Stürner C; Salamero M; Tolosa E; Poewe W; Santamaria J; Högl B; Sleep Med; 2011 Mar; 12(3):284-8. PubMed ID: 21317034 [TBL] [Abstract][Full Text] [Related]
37. Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Romenets SR; Gagnon JF; Latreille V; Panniset M; Chouinard S; Montplaisir J; Postuma RB Mov Disord; 2012 Jul; 27(8):996-1003. PubMed ID: 22733427 [TBL] [Abstract][Full Text] [Related]
39. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Mercuri NB; Bernardi G Trends Pharmacol Sci; 2005 Jul; 26(7):341-4. PubMed ID: 15936832 [TBL] [Abstract][Full Text] [Related]
40. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Iranzo A; Santamaría J; Rye DB; Valldeoriola F; Martí MJ; Muñoz E; Vilaseca I; Tolosa E Neurology; 2005 Jul; 65(2):247-52. PubMed ID: 16043794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]